Dexcom’s Stelo Continuous Glucose Monitor Now Available OTC In US

Dexcom announced the launch of Stelo, the first non-prescription continuous glucose monitoring system to hit the US market, but is likely going to face competition soon from Abbott.

• Source: Shutterstock

DexCom, Inc.’s Stelo continuous glucose monitor (CGM) became available in the US on 26 August for diabetics, prediabetics and healthy consumers alike, making it the first such product sold in the country that does not require a prescription.

While first to market, Dexcom is likely to face competition soon from its closest rival, Abbott , which is...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

Haleon Opens Start-Of-The-Art Oral Care R&D Facility In The UK

 
• By 

Haleon described the opening of a new oral care R&D facility in the UK as a “major investment reflecting our commitment to advancing science and innovation.”

Over The Counter: How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.

Lupin Goes For Growth With Indian Consumer Health Spin-Off

 
• By 

With annual sales approaching $20m, LupinLife Consumer Healthcare has ambitious growth plans for the Indian OTC market.

US Tariff Overhang Weighs on Chinese API Exports

 

Chinese API exports to US fell 24% year-on-year to $255m in May, when US and China called a truce in a previously escalating trade war.

More from Beauty

L’Oréal Plans Purchase Of Color Wow Brand

 

L’Oréal has signed an agreement to acquire the Color Wow professional styling brand for an undisclosed price.

US FDA’s Tough Talk On Talc: Regulating In An Echo Chamber

 

An FDA “expert roundtable” on talc produced a new talking point on a potential drug safety risk, but the basis of that claim is difficult to determine.

Scent News: Givaudan Buys Brazilian Fragrance House, DSM-Firmenich Taps Fine Fragrance President

 

Swiss fragrance company Givaudan SA will acquire Brazilian fragrance house Vollmens Fragrances, as DSM-Firmenich names Jonathan Simon president of fine fragrance.